A major limitation to single-cell protein (SCP) as a human food is its high nucleic acid content, the purine moiety of which is metabolised to uric acid. Rats given a Fusarium mould as a source of SCP in diets containing oxonate, a uricase inhibitor, showed elevated plasma and kidney uric acid concentrations after 21 d, which were related to the level of dietary mould. ADP-induced and thrombin-induced platelet aggregation was greater in the hyperuricaemic rats than in controls and a progressive increase in aggregation with increasing levels of dietary mould was observed. Furthermore a time-lag, exceeding the life-span of rat platelets, was observed between the development of hyperuricaemia and the increase in aggregation. A similar time-lag was observed between the lowering of the hyperuricaemia and the reduction of platelet aggregation when oxonate was removed from the diet.
If human platelets react to uric acid in the same manner as rat platelets this might explain the link that has been suggested between hyperuricaemia and ischaemic heart disease. In that event diets high in nucleic acids might be contra-indicated in people at risk from ischaemic heart disease.
In rats given a low protein diet (50 g casein/kg) for 21 d ADP-induced and thrombin-induced platelet aggregation and whole blood platelet count were reduced compared with control animals receiving 200 g casein/kg diet but not in rats given 90 or 130 g casein/kg diet. A study of the time course on this effect indicated that the reduction both in aggregation tendency and in whole blood platelet count occurred after 4 d of feeding the low protein diet. These values were further reduced with time.
References
1
Bang NU,
Heidenreich RO,
Trygstad CW.
1972; Plasma protein requirements for human platelet aggregation. Annals of the New York Academy of Sciences 201: 280
4
Brandenberger H.
1954; The oxidation of uric acid to oxonic acid (allantoxonic acid) and its application in tracer studies of uric acid biosynthesis. Biochimica et biophysica acta 15: 108
5
Brown JW.
1954; A quantitative study of cellular changes occurring in the bone marrow following protein deficiency in the rat. Anatomical Record 120: 515
7
Denson KWE,
Biggs R.
1972. Laboratory diagnosis, tests of clotting function and their standardization. In:
Biggs R.
(ed.) Human Blood Coagulation. Haemostasis and Thrombosis. Blackwell Scientific Publications; Oxford: p 278
8
Fridovich L.
1965; The competitive inhibition of uricase by oxonate and by related derivatives of s-triazines. Journal of Biological Chemistry 240 2 2491
12
Johnson WJ,
Stavric B,
Chartrand A.
1969; Uricase inhibition in the rat by s-triazines: An animal model for hyperuricaemia and hyperuricosuria. Proceedings of the Society for Experimental Biolog. Medicine 131: 8
14
Macmillan DC,
Sim AK.
1970; A comparative study of platelet aggregation in man and laboratory animals. Thrombosis et Diathesis Haemorrhagica 24: 385
16
Mustard JF,
Murphy EA,
Ogryzlo MA,
Smythe HA.
1963; Blood coagulation and platelet economy in subjects with primary gout. Canadian Medical Association Journal 89: 1207
18
Norrlind B,
Kihlberg R.
1972. A short assay for the estimation of dietary purine compounds, using a rat model system with inhibition of uricase. Report No. 35 Tillampad Mikrobiologi, Karolinska Institute; Stockholm:
19
Turner MR.
1973; Perinatal mortality, growth and survival to weaning in offspring of rats reared on diets moderately deficient in protein. British Journal of Nutrition 29: 139
